Chai Discovery Raises $130M for AI Drug Discovery
Update: 2025-12-16
Description
Chai Discovery, a biotech startup, secures $130M in Series B funding, valuing the company at $1.3B. Led by General Catalyst and Oak HC/FT, this round brings total capital raised to over $225M. Chai Discovery uses AI to accelerate drug discovery, with their latest model, Chai Two, significantly improving success rates for designing new antibodies. Founded by Josh Meier, a machine learning expert, the company aims to create a computer-aided design suite for molecules.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
